What is chloramphenicol Capsule used for?
Pharmaceutical Product Monograph: Chloramphenicol Capsules (250 mg / 500 mg)
In the pharmaceutical industry, Chloramphenicol is a potent, broad-spectrum antibiotic originally derived from Streptomyces venezuelae. As a pharmacist and manufacturer, I classify this as a “Reserve Antibiotic”—it is technically a highly effective molecule with nearly $100\%$ oral bioavailability, but due to its specific toxicity profile, it is reserved for life-threatening infections where other antibiotics have failed.
At your WHO-GMP facility in Mumbai, Chloramphenicol is a critical Essential Medicine SKU, particularly for export to markets where enteric fevers and meningitis are endemic.
Therapeutic Profile: Primary Indications
Chloramphenicol is indicated only for severe infections where the clinical benefits outweigh the risks of potential bone marrow toxicity.
| Indication | Clinical Context | Technical Rationale |
| Typhoid / Paratyphoid | Infectious Disease | Historically the gold standard for Enteric Fever; remains effective against many multi-drug resistant (MDR) strains. |
| Bacterial Meningitis | Neurology (Hospital) | Excellent penetration of the Blood-Brain Barrier (BBB); reaches therapeutic levels in the CSF even without inflamed meninges. |
| Rickettsial Infections | Tropical Medicine | Used for Rocky Mountain Spotted Fever and Typhus when Tetracyclines are contraindicated. |
| Anaerobic Infections | Surgical / Septicemia | Targets brain abscesses and severe intra-abdominal infections caused by Bacteroides fragilis. |
Mechanism: Protein Synthesis Inhibition (50S subunit)
Chloramphenicol works by sabotaging the “assembly line” of bacterial proteins:
Ribosomal Binding: The molecule binds reversibly to the 50S subunit of the bacterial ribosome.
Peptidyl Transferase Blockade: It specifically inhibits the enzyme Peptidyl Transferase, preventing the attachment of new amino acids to the growing peptide chain.
Bacteriostatic Action: By stopping protein production, it halts bacterial growth and replication.
High Lipophilicity: Its chemical structure allows it to diffuse easily into body tissues and the central nervous system.
The Pharmacist’s “Technical Warning” (Safety Clusters)
The “Gray Baby” Syndrome: Strictly contraindicated in newborns. Their immature livers cannot conjugate the drug, leading to toxic accumulation, abdominal distension, cyanosis (blue skin), and circulatory collapse.
Bone Marrow Suppression: 1. Dose-Related: Reversible anemia/leukopenia (common).
2. Idiosyncratic: Rare but fatal Aplastic Anemia (1 in 30,000 cases). This can occur weeks or months after treatment stops.
Drug Interactions: It is a potent inhibitor of hepatic enzymes (CYP450). It can dangerously increase blood levels of Warfarin, Phenytoin, and Sulfonylureas (diabetes meds).
Hematological Monitoring: Patients on Chloramphenicol must have a Complete Blood Count (CBC) every 48 hours.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at Healthy Life Pharma / Healthy Inc:
The “Reserve” USP: On your digital marketplace, position Chloramphenicol as a “Critical Care / Hospital Segment” product. It is not for general pharmacy retail but for institutional tenders and specialized clinics.
Stability in Export: Chloramphenicol is relatively stable. However, to maintain the high purity standards required to minimize side effects, ensure your Alu-Alu packaging is validated for “Zone IVb” to prevent any chemical degradation over its 36-month shelf life.
The “Export Specialty”: This is a high-volume product for UNICEF, WHO, and NGO tenders in sub-Saharan Africa and Southeast Asia for the management of epidemic meningitis.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers including “Bioavailability and Toxicity Summaries” to support your registration in international B2B markets.